DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Marinus Pharmaceuticals, Inc. (MRNS)
« Back to company indexMRNS Chatter Timeline
Stock Ticker for MRNS
Most Active Tweeters for MRNS
| User | Tweets |
|---|---|
| @AmericanBanking | 10 |
| @dakotafinancial | 5 |
| @dailypoliticaln | 4 |
| @Gambiste1 | 4 |
| @dispatchtribune | 4 |
Recent Tweets for MRNS
 |
@dakotafinancial Marinus Pharmaceuticals $MRNS Given “Buy” Rating at LADENBURG THALM/SH SH https://t.co/llSGsyiRJB November 19th 2019, 7:11pm |
 |
@TheMarketsDaily Marinus Pharmaceuticals $MRNS Given “Buy” Rating at LADENBURG THALM/SH SH https://t.co/rQUhz8ekyy November 19th 2019, 7:11pm |
 |
@gcassidy718 $MRNS major stock movement -4.13 % change recently https://t.co/KLHh2QG2dN November 19th 2019, 7:11pm |
 |
@SniggidySnipes So $MRNS gets Orphan Drug designation approval in the EU and the CEO is like... Better not press release it so our… https://t.co/pXBGIm8yyz November 19th 2019, 3:11pm |
 |
@BlueBioNow $MRNS Wake me up when we are green .. lol. ?????? -4.13 % change recently https://t.co/nVd1a7QnA7 November 19th 2019, 12:11pm |
 |
@dispatchtribune Marinus Pharmaceuticals Inc $MRNS Short Interest Down 11.1% in October https://t.co/qVeOk2vX8l November 18th 2019, 6:11pm |
 |
@EnterpriseLeade Marinus Pharmaceuticals Inc $MRNS Short Interest Down 11.1% in October https://t.co/UtOcfcesZR November 18th 2019, 6:11pm |
 |
@MysteriousMole1 RT @TradeHawk: $MRNS Marinus Pharmaceuticals gets EU Orphan Drug designation for Ganaxolone for the treatment of CDKL5 deficiency disorder… November 18th 2019, 3:11pm |
 |
@MatIsDoingShit $MRNS and when does the news actually come out November 18th 2019, 1:11pm |
 |
@MagicTickers $MRNS Orphan drug designation. Great chart! added at 1.07 You can't do this on your own we are here to help and te… https://t.co/eTyeTMTDIF November 18th 2019, 1:11pm |
 |
@magicmiketrader RT @dougbreitfelder: $MRNS Orphan drug designation. Great chart! added at 1.07 You can't do this on your own we are here to help and teach… November 18th 2019, 1:11pm |
 |
@Ultra_Calls $MRNS Raised stop to my entry 1.06. Mental stop. Not hard stop November 18th 2019, 1:11pm |
 |
@LargeVoidBot 13:27 Pops: $MRNS +5.6% November 18th 2019, 1:11pm |
 |
@dougbreitfelder $MRNS MOVING https://t.co/wTzGEnSLYS November 18th 2019, 1:11pm |
|
@dougbreitfelder $MRNS Orphan drug designation. Great chart! added at 1.07 You can't do this on your own we are here to help and te… https://t.co/GpKOj4kmhk November 18th 2019, 1:11pm |
|
@magicmiketrader $MRNS https://t.co/x7T4TXl5EM November 18th 2019, 1:11pm |
 |
@kreegs_23 $MRNS - Big news hasn't hit broker newswires yet! EU orphan drug designation: https://t.co/lAy5hrdnXA https://t.co/1mZEFCvbov November 18th 2019, 1:11pm |
|
@magicmiketrader $MRNS added $1.07 On orphan Drug designation news November 18th 2019, 1:11pm |
 |
@Jaldip15 $MRNS Procedure type: Orphan designation EMA number: EMA/OD/0000011311 November 18th 2019, 1:11pm |
|
@Ultra_Calls Added a nice position in $MRNS. I love this news. Once it hits the wire it will run hard. Marinus Pharmaceuticals… https://t.co/jqpVZgBd6q November 18th 2019, 1:11pm |
|
@Jaldip15 $MRNS added November 18th 2019, 1:11pm |
 |
@76enz $MRNS November 18th 2019, 1:11pm |
 |
@BottomPickerDTs $MRNS added on huge news ! November 18th 2019, 1:11pm |
|
@Ultra_Calls $MRNS WOW!!! Marinus Pharmaceuticals gets EU Orphan Drug designation for Ganaxolone for the treatment of CDKL5 de… https://t.co/zsYZy3sonU November 18th 2019, 1:11pm |
 |
@StockAlerts77 $MRNS Marinus Pharmaceuticals gets EU Orphan Drug designation for Ganaxolone for the treatment of CDKL5 deficiency disorder November 18th 2019, 1:11pm |
 |
@TradeHawk $MRNS Marinus Pharmaceuticals gets EU Orphan Drug designation for Ganaxolone for the treatment of CDKL5 deficiency… https://t.co/32enl0XvTt November 18th 2019, 1:11pm |
 |
@Gambiste1 RT @MysteriousMole1: @DemJustWarrior That study was shepherded by Joe Hulihan, who is now leading the development of ganaxolone at $MRNS as… November 18th 2019, 11:11am |
|
@MysteriousMole1 @DemJustWarrior That study was shepherded by Joe Hulihan, who is now leading the development of ganaxolone at $MRNS as CMO. November 18th 2019, 11:11am |
 |
@TranscriptDaily LADENBURG THALM/SH SH Reaffirms “Buy” Rating for Marinus Pharmaceuticals $MRNS https://t.co/7QEfO3X22N November 18th 2019, 8:11am |
|
@gcassidy718 $MRNS significant price change -3.54 % https://t.co/KLHh2QG2dN November 18th 2019, 8:11am |
 |
@stocknewstimes LADENBURG THALM/SH SH Reaffirms “Buy” Rating for Marinus Pharmaceuticals $MRNS https://t.co/a1OQHaz59I November 18th 2019, 8:11am |
 |
@AmericanBanking Marinus Pharmaceuticals $MRNS Earns Buy Rating from LADENBURG THALM/SH SH https://t.co/nktQ6QWxhh #stocks November 18th 2019, 8:11am |
|
@BlueBioNow $MRNS This one is getting bipolar : ) -3.54 % change recently https://t.co/nVd1a7QnA7 November 18th 2019, 12:11am |
 |
@ConsumerFeed HC Wainwright Reiterates Buy Rating for Marinus Pharmaceuticals $MRNS https://t.co/0sOwg1dNZQ November 18th 2019, 12:11am |
 |
@ZolmaxNews HC Wainwright Reiterates Buy Rating for Marinus Pharmaceuticals $MRNS https://t.co/3PWKm4OD20 November 18th 2019, 12:11am |
 |
@OlympiaReport Marinus Pharmaceuticals $MRNS Rating Reiterated by HC Wainwright https://t.co/ZiLfU4Z9H8 November 18th 2019, 12:11am |
|
@dispatchtribune Marinus Pharmaceuticals $MRNS Earns Buy Rating from HC Wainwright https://t.co/KDdobMUfuL November 18th 2019, 12:11am |
 |
@WatchlistN Marinus Pharmaceuticals $MRNS Earns “Buy” Rating from HC Wainwright https://t.co/midXHQLZph November 18th 2019, 12:11am |
|
@dakotafinancial Marinus Pharmaceuticals $MRNS Given “Buy” Rating at HC Wainwright https://t.co/265kFCggFo November 17th 2019, 11:11pm |
|
@Gambiste1 RT @newsfilterio: Form 3 (initial statement of beneficial ownership of securities) filed with the SEC 3 days ago $MRNS https://t.co/pJRm0kC… November 17th 2019, 3:11am |
 |
@newsfilterio Form 3 (initial statement of beneficial ownership of securities) filed with the SEC 3 days ago $MRNS https://t.co/pJRm0kCD0p November 17th 2019, 2:11am |
|
@ConsumerFeed Marinus Pharmaceuticals $MRNS Downgraded by Zacks Investment Research https://t.co/qzesenwNtf November 16th 2019, 5:11pm |
|
@WatchlistN Marinus Pharmaceuticals $MRNS Rating Lowered to Hold at Zacks Investment Research https://t.co/hS1y3KVAPA November 16th 2019, 5:11pm |
 |
@TickerReport Marinus Pharmaceuticals $MRNS Cut to “Hold” at Zacks Investment Research https://t.co/VZlnJNGLW9 November 16th 2019, 5:11pm |
|
@ZolmaxNews Marinus Pharmaceuticals $MRNS Downgraded by Zacks Investment Research to Hold https://t.co/UFhhksz6ZO November 16th 2019, 5:11pm |
 |
@dailypoliticaln Marinus Pharmaceuticals $MRNS Downgraded by Zacks Investment Research to Hold https://t.co/2HS7wnNlj7 November 16th 2019, 5:11pm |
|
@AmericanBanking Marinus Pharmaceuticals Inc $MRNS Sees Significant Drop in Short Interest https://t.co/jLyF4hS8bL #stocks November 16th 2019, 3:11pm |
|
@dakotafinancial Marinus Pharmaceuticals Inc $MRNS Sees Significant Drop in Short Interest https://t.co/bL49dKx4Ai November 16th 2019, 3:11pm |
|
@BlueBioNow $MRNS I’ll probably buy on the dip. Still need to do more research. -2.21 % https://t.co/nVd1a7QnA7 November 15th 2019, 11:11pm |
 |
@TheBestMenCanB1 $MRNS https://t.co/1KyUPw15aq November 15th 2019, 9:11am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2019. All rights reserved.